Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingJun 7, 2023Acetic Acid Otic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0781-2023Class IIOngoingJun 7, 2023Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0780-2023Class IIOngoingJun 7, 2023Atropine Sulfate Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0779-2023Class IIITerminatedJun 7, 2023Phenylephrine HCl 20 mg added to 0.9% Sodium Chloride 250mL BagProduct Mix up; Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium ChlorideNew England Life Care, Inc. dba Advanced Compounding Solutions · D-0778-2023Class IITerminatedJun 7, 2023Sodium Chloride 0.9% InjectionLack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.Fresenius Medical Care Holdings, Inc. · D-0777-2023Class IIOngoingJun 7, 2023HYDROmorphone HCl 10 mg in 0.9% Sodium ChloridgeCGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0776-2023Class IIOngoingJun 7, 2023Safe tussin PMCGMP Deviations: Use of non-food grade lubricant in mixing vessel.Denison Pharmaceuticals, LLC · D-0775-2023Class IIOngoingJun 7, 2023Pin-Away PYRENTAL PAMOATECGMP Deviations: Use of non-food grade lubricant in mixing vessel.Denison Pharmaceuticals, LLC · D-0774-2023Class IIOngoingJun 7, 2023Colic CalmCGMP Deviations: Use of non-food grade lubricant in mixing vessel.Denison Pharmaceuticals, LLC · D-0773-2023Class IIOngoingJun 7, 2023Safe tussin DMCGMP Deviations: Use of non-food grade lubricant in mixing vessel.Denison Pharmaceuticals, LLC · D-0772-2023Class IIOngoingMay 31, 2023Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL VialSub-potent DrugRevive Rx LLC dba Revive Rx Pharmacy · D-0771-2023Class IIITerminatedMay 31, 2023Fentanyl Buccal Tablets CIILabeling: Incorrect or Missing Package InsertTeva Pharmaceuticals USA Inc · D-0770-2023Class IIITerminatedMay 31, 2023Fentanyl Buccal Tablets CIILabeling: Incorrect or Missing Package InsertTeva Pharmaceuticals USA Inc · D-0769-2023Class IIITerminatedMay 31, 2023Fentanyl Buccal Tablets CIILabeling: Incorrect or Missing Package InsertTeva Pharmaceuticals USA Inc · D-0768-2023Class IIITerminatedMay 31, 2023Fentanyl Buccal Tablets CIILabeling: Incorrect or Missing Package InsertTeva Pharmaceuticals USA Inc · D-0767-2023Class IIITerminatedMay 31, 2023Fentanyl Buccal Tablets CIILabeling: Incorrect or Missing Package InsertTeva Pharmaceuticals USA Inc · D-0766-2023Class IICompletedMay 31, 2023Pain RelieverFailed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an...Aurobindo Pharma USA Inc. · D-0765-2023Class IIOngoingMay 31, 2023Nafcillin for InjectionLack of Assurance of SterilitySagent Pharmaceuticals Inc · D-0764-2023Class IIOngoingMay 31, 2023Nafcillin for InjectionLack of Assurance of SterilitySagent Pharmaceuticals Inc · D-0763-2023Class IIOngoingMay 31, 2023Nafcillin for InjectionLack of Assurance of SterilitySagent Pharmaceuticals Inc · D-0762-2023Class IITerminatedMay 31, 2023buPROPrion Hydrochloride Extended-Release TabletsFailed Dissolution Specifications; during stability testingSun Pharmaceutical Industries Inc · D-0761-2023Class IITerminatedMay 31, 2023FOAMING HAND SANITIZERCGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.Alpha Aromatics · D-0760-2023Class IITerminatedMay 31, 2023Glimepiride TabletsCGMP Deviations: recalling drug products following an FDA inspection.Amerisource Health Services LLC · D-0759-2023Class IITerminatedMay 31, 2023Glimepiride TabletsCGMP Deviations: recalling drug products following an FDA inspection.Amerisource Health Services LLC · D-0758-2023Class IITerminatedMay 31, 2023Glimepiride TabletsCGMP Deviations: recalling drug products following an FDA inspection.Amerisource Health Services LLC · D-0757-2023Class IIITerminatedMay 31, 2023Methylprednisolone Acetate Injectable SuspensionLabeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only)...Amneal Pharmaceuticals of New York, LLC · D-0756-2023Class IITerminatedMay 31, 2023HyperLyte CR InjectionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0755-2023Class IITerminatedMay 31, 2023HyperLyte CR InjectionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0754-2023Class IITerminatedMay 31, 2023Lidocaine 2% HCl InjLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0753-2023Class IITerminatedMay 31, 2023Potassium Acetate InjectionLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0752-2023Class IITerminatedMay 31, 2023Sodium Phosphates Injection 4 mEq/3 mMol/mLLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0751-2023Class IITerminatedMay 31, 2023MSA 7.84% MSG 8.56%Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0750-2023Class IITerminatedMay 31, 2023vasopressin 50 units added to 0.9% sodium chloride 50 mL*Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0749-2023Class IITerminatedMay 31, 2023vasopressin 40 units added to 0.9% sodium chloride 100 mL*Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0748-2023Class IITerminatedMay 31, 2023vasopressin 20 units added to 0.9% sodium chloride 100 mL*Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0747-2023Class IITerminatedMay 31, 2023heparin added to 0.9% sodium chlorideLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0746-2023Class IITerminatedMay 31, 2023NORepinephrine added to 0.9% sodium chlorideLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0745-2023Class IITerminatedMay 31, 2023NORepinephrine added to 0.9% sodium chlorideLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0744-2023Class IITerminatedMay 31, 2023NORepinephrine added to dextrose 5%Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0743-2023Class IITerminatedMay 31, 2023EPINEPHrine added to 0.9% sodium chlorideLack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.Central Admixture Pharmacy Services, Inc. · D-0742-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.